摘要
Tumor angiogenesis is the proliferation of a network of blood vessels that penetrates into cancerous growths, supplying nutrients and oxygen and removing waste products. The process of angiogenesis plays an important role in many physiological and pathological conditions. Solid tumors depend on angiogenesis for growth and metastasis in a hostile environment. In the prevascular phase, the tumor is rarely larger than 2 to 3 mm3 and may contain a million or more cells. Up to this size, tumor cells can obtain the necessary oxygen and nutrient supplies required for growth and survival by simple passive diffusion. The properties of tumors to release and induce several angiogenic and antiangiogenic factors which play crucial roles in regulating endothelial cell (EC) proliferation, migration, apoptosis or survival, cell-cell and cell-matrix adhesion through different intracellular signaling are thought to be the essential mechanisms during tumor-induced angiogenesis. Tumor angiogenesis actually starts with tumor cells releasing molecules that send signals to surrounding normal host tissue. This signaling activates certain genes in the host tissue that, in turn, make proteins to encourage growth of new blood vessels. In this review, we focus the mechanisms of tumor-induced angiogenesis, with an emphasis on the regulatory role of several angiogenic and anti-angiogenic agents during the angiogenic process in tumors. Advances in understanding the mechanisms of tumor angiogenesis have led to the development of several most effective antiangiogenic and anti-metastatic therapeutic agents and also have provided several techniques for the regulation of cancer's angiogenic switch. The suggestion is made that standard cytotoxic chemotherapy and angiogenesis inhibitors used in combination may produce complementary therapeutic benefits in the treatment of cancer.
Tumor angiogenesis is the proliferation of a network of blood vessels that penetrates into cancerous growths,supplying nutrients and oxygen and removing waste products.The process of angiogenesis plays an important role in many physiological and pathological conditions.Solid tumors depend on angiogenesis for growth and metastasis in a hostile environment.In the prevascular phase,the tumor is rarely larger than 2 to 3 mm^3 and may contain a million or more cells.Up to this size,tumor cells can obtain the necessary oxygen and nutrient supplies required for growth and survival by simple passive diffusion.The properties of tumors to release and induce several angiogenic and anti- angiogenic factors which play crucial roles in regulating endothelial cell (EC) proliferation,migration,apoptosis or survival,cell-cell and cell-matrix adhesion through different intracellular signaling are thought to be the essential mechanisms during tumor-induced angiogenesis.Tumor angiogenesis actually starts with tumor cells releasing molecules that send signals to surrounding normal host tissue.This signaling activates certain genes in the host tissue that,in turn,make proteins to encourage growth of new blood vessels.In this review,we focus the mechanisms of tumor-induced angiogenesis,with an emphasis on the regulatory role of several angiogenic and anti-angiogenic agents during the angiogenic process in tumors.Advances in understanding the mechanisms of tumor angiogenesis have led to the development of several most effective anti- angiogenic and anti-metastatictherapeutic agents and also have provided several techniques for the regulation of cancer's angiogenic switch.The suggestion is made that standard cytotoxic chemotherapy and angiogenesis inhibitors used in combination may produce complementary therapeutic benefits in the treatment of cancer.
基金
National Natural Science Foundation of China,No 30271473
